Web13 jan. 2024 · Johnson & Johnson (NYSE:JNJ) 5-Year EBITDA Growth Rate. View and export this data going back to 1944. Start your Free Trial. Johnson & Johnson's EBITDA … WebEarnings growth (last year)-13.84%: Earnings growth (this year) +3.58%: Earnings growth (next 5 years) +4.58%: Revenue growth (last year) +1.34%: P/E ratio: 24.7: …
IHI vs JNJ - EV to EBIT Ratio Chart - Current & Historical Data
Web13 apr. 2024 · Johnson & Johnson has generated $6.74 earnings per share over the last year ($6.74 diluted earnings per share) and currently has a price-to-earnings ratio of 24.5. Earnings for Johnson & Johnson are expected to grow by 4.10% in the coming year, from $10.50 to $10.93 per share. WebOn average, 6 Wall Street analysts forecast JNJ's revenue for 2024 to be $254,500,777,255,688, with the lowest JNJ revenue forecast at $253,522,063,024,444, and the highest JNJ revenue forecast at $255,506,529,187,330. drawings of football players
Johnson & Johnson (JNJ) Market Cap & Net Worth - Stock Analysis
WebCompare the roic of iShares U.S. Medical Devices ETF IHI and Johnson & Johnson JNJ. Get comparison charts for value investors! Popular Screeners Screens. Biggest Companies Most Profitable Best Performing Worst Performing 52-Week Highs 52-Week Lows Biggest Daily Gainers Biggest Daily Losers Most Active Today Best Growth Stocks. Web6 apr. 2024 · Find the latest historical data for Johnson & Johnson Common Stock (JNJ) at Nasdaq.com. Johnson & Johnson Common Stock (JNJ) Historical Data Nasdaq Skip to … WebJohnson & Johnson balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View JNJ financial statements in full. drawings of forest trees